about
Sex Differences in Long-Term Mortality After Stroke in the INSTRUCT (INternational STRoke oUtComes sTudy): A Meta-Analysis of Individual Participant Data.The ExStroke Pilot Trial: rationale, design, and baseline data of a randomized multicenter trial comparing physical training versus usual care after an ischemic stroke.Risk Factors and Etiology of Young Ischemic Stroke Patients in EstoniaLong-term survival of young stroke patients: a population-based study of two stroke registries from Tartu, EstoniaExStroke Pilot Trial of the effect of repeated instructions to improve physical activity after ischaemic stroke: a multinational randomised controlled clinical trial.Mortality and causes of death after traumatic spinal cord injury in Estonia.Intravenous thrombolysis for ischemic stroke in the golden hour: propensity-matched analysis from the SITS-EAST registry.A New Risk Factor for Traumatic Spinal Cord Injury.Do Stroke Patients Know Their Risk Factors?Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke.Intravenous Thrombolysis for Stroke Recurring Within 3 Months From the Previous Event.Management of ischemic stroke in Central and Eastern Europe.Headaches after traumatic spinal cord injury in Estonia.Stroke in the young 2012Angiotensin receptor blockade in acute stroke. The Scandinavian Candesartan Acute Stroke Trial: rationale, methods and design of a multicentre, randomised- and placebo-controlled clinical trial (NCT00120003).The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial.Benefit of thrombolysis for stroke is maintained around the clock: results from the SITS-EAST Registry.Acute stroke: why do some patients arrive in time and others do not?Traumatic spinal cord injury in two European countries: why the differences?High incidence of traumatic spinal cord injury in Estonia.One-year outcome after first-ever stroke according to stroke subtype, severity, risk factors and pre-stroke treatment. A population-based study from Tartu, Estonia.Prestroke physical activity is associated with severity and long-term outcome from first-ever stroke.Health-related quality of life in patients with traumatic spinal cord injury in Estonia.Clinical outcome of cardioembolic stroke treated by intravenous thrombolysis.Brain activation in the chronic phase of traumatic spinal cord injury.Factors influencing in-hospital delay in treatment with intravenous thrombolysis.Intravenous thrombolysis for patients with in-hospital stroke onset: propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry.Lifestyle and late effects after poliomyelitis. A risk factor study of two populations.European Academy of Neurology and European Stroke Organization consensus statement and practical guidance for pre-hospital management of stroke.Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcome.Functional MRI of the cortical sensorimotor system in patients with hereditary spastic paraplegia.Hyperdense cerebral artery computed tomography sign is associated with stroke severity rather than stroke subtype.Factors influencing door-to-imaging time: analysis of the safe implementation of treatments in Stroke-EAST registry.Impact of fatal cases on the epidemiology of traumatic spinal cord injury in Estonia.Underfunding of stroke research: a Europe-wide problem.Brain activation in the acute phase of traumatic spinal cord injury.Factors contributing to sex differences in functional outcomes and participation after strokeBurden of Stroke in EstoniaThe Third Stroke Registry in Tartu, Estonia, from 2001 to 2003The Third Stroke Registry in Tartu, Estonia
P50
Q31164932-846CD579-9906-4ADC-8CD7-8DDCA459CAF6Q33306648-4998BD18-ABF3-4A6A-92F8-1F1418C2C06EQ33862431-C13D9F94-1EF4-49BD-BD2F-962BA59483FBQ35915089-B64A49C5-F499-4370-9DB0-E20305F3B0C9Q37272036-ABB7F130-3A9E-4BAC-B502-1940B75F581FQ37317790-E7C86376-3AF2-4467-A28F-2B3C5FEEEEF3Q38896148-59963F95-CE21-43BC-8B99-E295BC264273Q39856525-776F563C-8392-472C-A57B-1103C6A1A1F5Q40225272-3139DDB5-D924-44C5-927C-16A798586725Q40738132-CA935F9F-8228-43A5-92E6-6EBED09435D0Q41243045-427D10FE-30F5-4FA2-9C0E-42E2A2E09064Q41583031-DEBB4F95-6134-4A56-A2F8-AC78B5674A87Q41660911-331800BA-3669-487A-A005-4C5A3E319B37Q42123845-2D3C2534-0206-40D0-92D4-77633115FBB3Q42883562-40A1ADC2-B033-47EF-BEF3-6A68EE748962Q43735561-00DC26E6-4928-4597-9862-DA9302A55488Q43767033-26E7BD3E-713D-4BF0-AC60-B3C1F1988D6DQ44001798-0E668E79-81DF-44AA-A5B7-2F4DFE2170A7Q44317616-80252D57-034D-4BEF-823F-21FBF97DD283Q44471963-5045A0B6-38CF-4259-86E2-607EB7983A8AQ44481914-A597D2A4-54BE-497E-92A4-C9965A5CFC81Q44653279-0D870F2B-1E48-4806-8BF9-097DACD5310DQ45323487-48B6154B-F97A-46CC-ACAA-474C0873E5CDQ47346247-B3A21CA4-B57D-413A-AFC1-46A805F116CDQ48003245-8D9067AE-1FEC-4851-B419-DD512015FEE2Q48009713-A9B86B78-6EBD-4354-B6C3-42B8635425B4Q48009791-8F4EDCF7-9CE1-497C-BCE8-96BB1353F85CQ48035192-A97A7BAF-95A6-45FA-A0F7-7E5FB3054D12Q48154485-06C1B7F6-2F29-46EC-9EFB-B42B2589706CQ48238916-338A615D-1F3D-4825-B59F-78DA9AE9DA9AQ48453871-96F3B6A9-2FDE-4A4A-A382-D741C60EC17BQ48505938-77A1A500-4396-4484-8E7C-1AC48D7851D3Q48614330-C4ADCD7B-1E36-4C71-8EDF-1ECEB9E46A03Q50667025-BBF9A87C-FE9E-4B6D-8258-6AE241407D05Q50747571-9A92DE91-359A-4C71-97A4-A93656D14A98Q50853211-558EA976-3AC9-482A-8622-B624AE6FEF26Q60636225-F8EC16AA-EFAF-4581-8DAE-13266B06B172Q60636237-103CBF2C-4265-4246-BF17-CED877FC5AEDQ60636267-4206139F-EDB2-46A0-A863-71F5E7C60754Q60636270-85390267-683E-47EE-A9C7-E1E1BAC3370B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Janika Kõrv
@ast
Janika Kõrv
@en
Janika Kõrv
@es
Janika Kõrv
@nl
Janika Kõrv
@sl
type
label
Janika Kõrv
@ast
Janika Kõrv
@en
Janika Kõrv
@es
Janika Kõrv
@nl
Janika Kõrv
@sl
prefLabel
Janika Kõrv
@ast
Janika Kõrv
@en
Janika Kõrv
@es
Janika Kõrv
@nl
Janika Kõrv
@sl
P1053
I-4395-2015
P106
P1153
6602337786
P21
P31
P3829
P496
0000-0002-6074-0727